Eric McIntyre | Head-Investor Relations |
Frank Watanabe | President & Chief Executive Officer |
Ayisha Jeter | Interim-Chief Commercial Officer |
Patrick Burnett | Chief Medical Officer |
Scott Burrows | Chief Financial Officer |
Tyler Van Buren | TD Cowen |
Vikram Purohit | Morgan Stanley |
Seamus Fernandez | Guggenheim Securities |
Uy Ear | Mizuho |
Louise Chen | Cantor |
Sean Kim | JonesTrading |
Rohit Bhasin | Needham |
Good day and thank you for standing by. Welcome to the Arcutis Biotherapeutics Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] Please be advised that today's conference call is being recorded.